Why is this medication prescribed?

Entyvio is a medication primarily prescribed for the treatment of inflammatory bowel diseases (IBD), specifically ulcerative colitis and Crohn’s disease. These are chronic conditions characterized by inflammation of the digestive tract.

Entyvio (vedolizumab) works by targeting a specific protein involved in the inflammation process, thereby helping to reduce inflammation and symptoms associated with ulcerative colitis and Crohn’s disease.

How should this medicine be used?

Here’s how Entyvio is typically used:

• Dosage: The dosage of Entyvio can vary based on factors such as the individual’s weight, severity of the condition, and response to treatment. It is typically administered as an intravenous infusion.
• Administration: Entyvio is usually administered by a healthcare professional in a clinical setting such as a hospital or infusion center. The infusion process may take around 30 minutes to an hour, depending on the dose.
• Frequency: Initially, Entyvio infusions are often given at specific intervals, such as every 2 weeks for a few doses, followed by every 4 weeks thereafter. However, the specific dosing schedule may vary depending on the individual’s response to treatment.
• Monitoring: Regular monitoring by a healthcare provider is important during Entyvio treatment to assess its effectiveness and monitor for any potential side effects or complications.
• Duration: Entyvio is often used as a long-term treatment for managing symptoms and maintaining remission in ulcerative colitis and Crohn’s disease. However, the duration of treatment can vary depending on individual circumstances and response to the medication.

It’s important for individuals prescribed Entyvio to follow their healthcare provider’s instructions carefully and attend all scheduled appointments for monitoring and administration of the medication. Additionally, they should report any new or worsening symptoms to their healthcare provider promptly.

Other uses for this medicine

Entyvio (vedolizumab) is primarily used for the treatment of inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease. However, it’s important to note that this medication is not approved for other conditions, and its use should be strictly guided by a healthcare professional.

What special precautions should I follow?

As for special precautions to follow while using Entyvio:

• Infections: Entyvio works by suppressing the immune system to reduce inflammation, which can increase the risk of infections. Individuals using Entyvio should avoid close contact with people who have contagious illnesses, such as colds or the flu. Additionally, they should promptly report any signs or symptoms of infection to their healthcare provider, such as fever, chills, cough, or sore throat.
• Vaccinations: Before starting Entyvio treatment, individuals should ensure they are up-to-date with all recommended vaccinations. However, live vaccines should generally be avoided while on Entyvio therapy due to the risk of causing infection. It’s essential to discuss vaccination schedules and options with a healthcare provider.
• Monitoring: Regular monitoring by a healthcare provider is crucial while using Entyvio to assess its effectiveness and monitor for any potential side effects or complications. This may include periodic blood tests and evaluations of the digestive tract.
• Allergic Reactions: Some individuals may experience allergic reactions to Entyvio. Signs of an allergic reaction may include rash, itching, difficulty breathing, or swelling of the face, lips, tongue, or throat. If any of these symptoms occur, immediate medical attention should be sought.
• Liver Function: Entyvio may affect liver function, so individuals with liver disease or abnormal liver function tests should be monitored closely while using this medication.
• Pregnancy and Breastfeeding: The safety of Entyvio during pregnancy and breastfeeding is not well established. Therefore, individuals who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits of Entyvio with their healthcare provider.
• Other Medications: Before starting Entyvio treatment, individuals should inform their healthcare provider about all medications they are taking, including prescription, over-the-counter, and herbal supplements. Some medications may interact with Entyvio, potentially affecting its effectiveness or increasing the risk of side effects.

It’s essential to follow all healthcare provider instructions and guidelines while using Entyvio to ensure safe and effective treatment. Any questions or concerns about Entyvio should be discussed with a healthcare professional.

What special dietary instructions should I follow?

Special dietary instructions for Entyvio are generally not required. However, individuals with inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease may benefit from following dietary guidelines recommended by their healthcare provider to manage symptoms.

What should I do if I forget a dose?

If you forget a dose of Entyvio, contact your healthcare provider as soon as possible for guidance. Do not double the dose to make up for a missed one unless instructed by your healthcare provider. It’s important to adhere to the prescribed dosing schedule to maintain the effectiveness of the medication.

What side effects can this medication cause?

Entyvio (vedolizumab) is generally well-tolerated, but like any medication, it can cause side effects in some individuals. Common side effects of Entyvio may include:

• Headache: Some individuals may experience headaches during or after receiving Entyvio infusions.
• Fatigue: Feeling tired or fatigued is a common side effect reported by some individuals using Entyvio.
• Nausea: Nausea or an upset stomach may occur as a side effect of Entyvio treatment.
• Fever: Some individuals may experience a mild fever after receiving Entyvio infusions.
• Sore Throat: Entyvio may occasionally cause a sore throat or discomfort in the throat.
• Nasopharyngitis: This refers to inflammation of the nasal passages and throat, which may cause symptoms such as a runny or stuffy nose, sneezing, and sore throat.
• Joint Pain: Some individuals may experience joint pain or discomfort as a side effect of Entyvio.
• Infusion Reactions: Rarely, individuals may experience infusion reactions during or shortly after receiving Entyvio infusions. Symptoms of infusion reactions may include fever, chills, headache, rash, itching, shortness of breath, or dizziness.
• Infections: Entyvio suppresses the immune system, which can increase the risk of infections. Common infections reported by individuals using Entyvio include respiratory infections (such as the common cold), urinary tract infections, and sinus infections.
• Liver Function Abnormalities: Entyvio may cause abnormalities in liver function tests in some individuals.

It’s important to note that while these side effects can occur, not everyone will experience them, and some individuals may experience side effects not listed here. Additionally, serious side effects are possible but rare. If you experience any concerning symptoms or side effects while using Entyvio, it’s essential to contact your healthcare provider for evaluation and guidance. They can help determine the appropriate course of action, which may include adjusting your treatment plan or addressing any potential complications.

What should I know about storage and disposal of this medication?

Storage and Disposal:

• Storage: Entyvio (vedolizumab) is typically supplied as a sterile solution in single-dose vials or prefilled syringes. It should be stored in the refrigerator at a temperature between 36°F to 46°F (2°C to 8°C). Do not freeze Entyvio. Keep it in its original carton to protect it from light. Do not use Entyvio beyond the expiration date printed on the packaging.
• Disposal: Unused or expired Entyvio should be disposed of properly according to local regulations for handling medical waste. Do not dispose of Entyvio in household trash or flush it down the toilet. Contact your healthcare provider, pharmacist, or local waste management authority for guidance on safe disposal methods.

In case of emergency/overdose

In case of an emergency or overdose involving Entyvio, contact your local poison control center or seek emergency medical assistance immediately. The specific management of an overdose may vary depending on the individual’s symptoms and circumstances. It’s essential to inform healthcare professionals about the medication involved and provide as much information as possible about the situation.

What other information should I know?

• Entyvio is a prescription medication and should only be used under the supervision of a healthcare provider experienced in the treatment of inflammatory bowel diseases (IBD).
• Before starting Entyvio treatment, inform your healthcare provider about any medical conditions you have, especially infections or a history of allergic reactions.
• Inform your healthcare provider about all medications you are taking, including prescription, over-the-counter, and herbal supplements, as they may interact with Entyvio.
• Attend all scheduled appointments for Entyvio infusions and follow-up visits with your healthcare provider for monitoring and evaluation of your condition.
• Report any new or worsening symptoms to your healthcare provider promptly, including signs of infection, allergic reactions, or infusion reactions.
• Do not receive live vaccines while using Entyvio, as it may affect your body’s ability to respond to the vaccine.
• Keep Entyvio out of the reach of children and pets.
• Store Entyvio vials or prefilled syringes in their original packaging until ready to use to protect them from light and contamination.

Following these guidelines can help ensure the safe and effective use of Entyvio and minimize the risk of complications or adverse events. If you have any questions or concerns about Entyvio or its use, consult your healthcare provider for further information and guidance.